TWEAK/Fn14 activation induces keratinocyte proliferation under psoriatic inflammation

Experimental Dermatology

Volumn 25, Issue 1, 2016, Pages 32-37

  Cheng, Hong ^a   Xu, Meifeng ^a   Liu, Xiaoming ^b   Zou, Xiaoyan ^c   Zhan, Na ^d   Xia, Yumin ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c Hubei Maternal and Child Health Hospital   (China)

^d RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Inflammation; Keratinocyte; Proliferation; Psoriasis; TWEAK Fn14 pathway

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR INDUCIBLE 14; FLICE INHIBITORY PROTEIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 2; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 6; KI 67 ANTIGEN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYC PROTEIN; RANTES; SMALL INTERFERING RNA; SURVIVIN; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR LIKE WEAK INDUCER OF APOPTOSIS; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; VASCULOTROPIN; BIRC5 PROTEIN, HUMAN; CYTOKINE; LIGAND; TNFSF12 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR; TWEAK RECEPTOR;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL INFILTRATION; CELL LYSATE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATION; KERATINOCYTE; MACROPHAGE; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PSORIASIS VULGARIS; RNA ANALYSIS; SIGNAL TRANSDUCTION; SKIN DEFECT; UPREGULATION; CYTOLOGY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; PATHOLOGY; PSORIASIS;

APOPTOSIS; CELL PROLIFERATION; CYTOKINES; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INHIBITOR OF APOPTOSIS PROTEINS; KERATINOCYTES; LIGANDS; NF-KAPPA B; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTORS;

EID: 84954025677     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12820     Document Type: Article

References (54)

1. Gudjonsson J E, Johnston A, Sigmundsdottir H et al. Clin Exp Immunol 2004: 135: 1-8.
2. Oka A, Mabuchi T, Ozawa A et al. J Dermatol 2012: 39: 231-241.
3. Peternel S, Kastelan M. J Eur Acad Dermatol Venereol 2009: 23: 1123-1127.
4. Coimbra S, Figueiredo A, Castro E et al. Int J Dermatol 2012: 51: 389-395.
5. Kastelan M, Prpić-Massari L, Brajac I. Acta Dermatovenerol Croat 2009: 17: 182-186.
6. Weatherhead S C, Farr P M, Jamieson D et al. J Invest Dermatol 2011: 131: 1916-1926.
7. Tiberio R, Bozzo C, Pertusi G et al. Clin Exp Dermatol 2009: 34: e972-e974.
8. Xia Y, Campbell S R, Broder A et al. Clin Immunol 2012: 145: 108-121.
9. Xia Y, Herlitz L C, Gindea S et al. J Am Soc Nephrol 2015: 26: 1053-1070.
10. Jin L, Nakao A, Nakayama M et al. J Invest Dermatol 2004: 122: 1175-1179.
11. Zimmermann M, Koreck A, Meyer N et al. J Allergy Clin Immunol 2011: 127: 200-207, 207.e1-207.e10.
12. Chen T, Guo Z P, Li M et al. Clin Exp Immunol 2011: 166: 64-71.
13. de Araujo E, Dessirier V, Laprée G et al. Exp Dermatol 2011: 20: 107-112.
14. Li M, Chen T, Guo Z et al. J Dermatol 2013: 40: 891-895.
15. Rateb A A, Fawzi M M, Abdel Hay R M et al. Eur J Dermatol 2012: 22: 481-487.
16. Fujita H, Shemer A, Suárez-Fariñas M et al. J Allergy Clin Immunol 2011: 128: 574-582.e1-e12.
17. Martin G, Guérard S, Fortin M M et al. Lab Invest 2012: 92: 1058-1070.
18. Zou X Y, Ding D, Zhan N et al. J Invest Dermatol 2015: 135: 589-598.
19. Rohani M G, Pilcher B K, Chen P et al. J Invest Dermatol 2014: 134: 1230-1237.
20. Guilloteau K, Paris I, Pedretti N et al. J Immunol 2010: 184: 5263-5270.
21. Sabour Alaoui S, Dessirier V, de Araujo E et al. PLoS One 2012: 7: e33609.
22. Doerner J, Wen J, Xia Y et al. J Invest Dermatol 2015: 135: 1986-1995.
23. Peternel S, Manestar-Blažić T, Brajac I et al. J Cutan Pathol 2011: 38: 780-789.
24. Teng X, Hu Z, Wei X et al. J Immunol 2014: 192: 1815-1823.
25. Choe Y B, Hwang Y J, Hahn H J et al. Br J Dermatol 2012: 167: 762-767.
26. Cai Y, Shen X, Ding C et al. Immunity 2011: 35: 596-610.
27. Nakajima K. J Dermatol 2012: 39: 219-224.
28. Takahashi H, Tsuji H, Hashimoto Y et al. Clin Exp Dermatol 2010: 35: 645-649.
29. O'Kane M, Markham T, McEvoy A N et al. J Invest Dermatol 2008: 128: 300-310.
30. Yu H, Mrowietz U, Seifert O. Acta Derm Venereol 2009: 89: 351-356.
31. Takei-Taniguchi R, Imai Y, Ishikawa C et al. J Dermatol 2012: 39: 625-631.
32. Harada N, Nakayama M, Nakano H et al. Biochem Biophys Res Commun 2002: 299: 488-493.
33. Jakubowski A, Ambrose C, Parr M et al. J Clin Invest 2005: 115: 2330-2340.
34. Michaelson J S, Cho S, Browning B et al. Oncogene 2005: 24: 2613-2624.
35. Desplat-Jégo S, Varriale S, Creidy R et al. J Neuroimmunol 2002: 133: 116-123.
36. Chorianopoulos E, Heger T, Lutz M et al. Basic Res Cardiol 2010: 105: 301-313.
37. Roos C, Wicovsky A, Müller N et al. J Immunol 2010: 185: 1593-1605.
38. Campbell S, Burkly L C, Gao H X et al. J Immunol 2006: 176: 1889-1898.
39. Seitz C S, Lin Q, Deng H et al. Proc Natl Acad Sci U S A 1998: 95: 2307-2312.
40. Weng Z, Patel A B, Vasiadi M et al. PLoS One 2014: 9: e90739.
41. Yang J, Li Y, Liu Y Q et al. Eur J Dermatol 2009: 19: 29-33.
42. Winkles J A, Tran N L, Brown S A et al. Front Biosci 2007: 12: 2761-2771.
43. Faustman D, Davis M. Nat Rev Drug Discov 2010: 9: 482-493.
44. Kerstan A, Bröcker E B, Trautmann A. Arch Dermatol Res 2011: 303: 651-658.
45. Arnott C H, Scott K A, Moore R J et al. Oncogene 2004: 23: 1902-1910.
46. Holtmann M H, Douni E, Schütz M et al. Eur J Immunol 2002: 32: 3142-3151.
47. Wei X, Gong J, Zhu J et al. Clin Immunol 2008: 129: 211-218.
48. Simon M Jr, Gruschwitz M S. Acta Derm Venereol 1997: 77: 191-193.
49. Campanati A, Orciani M, Gorbi S et al. Br J Dermatol 2012: 167: 68-76.
50. Caldarola G, De Simone C, Carbone A et al. Int J Immunopathol Pharmacol 2009: 22: 961-966.
51. Gottlieb A B, Chamian F, Masud S et al. J Immunol 2005: 175: 2721-2729.
52. Razmara M, Hilliard B, Ziarani A K et al. Am J Pathol 2009: 174: 460-474.
53. Wicovsky A, Salzmann S, Roos C et al. Cell Death Differ 2009: 16: 1445-1459.
54. Nakayama M, Kayagaki N, Yamaguchi N et al. J Exp Med 2000: 192: 1373-1380.